Article Versions Notes

Karmi O, Sohn Y-S, Marjault H-B, Israeli T, Leibowitz G, Ioannidis K, Nahmias Y, Mittler R, Cabantchik IZ, Nechushtai R. A Combined Drug Treatment That Reduces Mitochondrial Iron and Reactive Oxygen Levels Recovers Insulin Secretion in NAF-1-Deficient Pancreatic Cells. Antioxidants. 2021; 10(8):1160. https://doi.org/10.3390/antiox10081160

Karmi, Ola, Yang-Sung Sohn, Henri-Baptiste Marjault, Tal Israeli, Gil Leibowitz, Konstantinos Ioannidis, Yaakov Nahmias, Ron Mittler, Ioav Z. Cabantchik, and Rachel Nechushtai. 2021. "A Combined Drug Treatment That Reduces Mitochondrial Iron and Reactive Oxygen Levels Recovers Insulin Secretion in NAF-1-Deficient Pancreatic Cells" Antioxidants 10, no. 8: 1160. https://doi.org/10.3390/antiox10081160

Karmi, O., Sohn, Y.-S., Marjault, H.-B., Israeli, T., Leibowitz, G., Ioannidis, K., Nahmias, Y., Mittler, R., Cabantchik, I. Z., & Nechushtai, R. (2021). A Combined Drug Treatment That Reduces Mitochondrial Iron and Reactive Oxygen Levels Recovers Insulin Secretion in NAF-1-Deficient Pancreatic Cells. Antioxidants, 10(8), 1160. https://doi.org/10.3390/antiox10081160